112 results
DEFA14A
QTNTQ
Quotient Ltd
27 Jul 20
Additional proxy soliciting materials
4:22pm
proposed at the AGM.
As noted in the attached Notice of AGM and proxy materials, in accordance with the “notice and access” rules and regulations adopted … documentation which would contain information on how to access relevant notices, proxy materials and other assimilated information via a website.
If you
8-K
EX-99.1
QTNTQ
Quotient Ltd
4 Nov 19
Positive results from the initial Serological Disease Screening microarray US field trial
7:14am
expected.There were also slight delays with IH II due to a raw material supply challenge, which we have now resolved, and delayed access to certain rare … sample material required for verification testing.” Mr. Walt added, “We are now focused on menu expansion and market access and this quarter’s
8-K
EX-99.1
QTNTQ
Quotient Ltd
24 Jun 22
Results of Operations and Financial Condition
8:02am
time to the development of Autoimmune microarray with optimized costs; Will expand access to $2 billion autoimmune IVD specialty market with MosaiQ … on June 24th, 2022, at 8:00 a.m. Eastern Time to provide a business update. Participants may access the call by dialing 1-877-407-0784 in the U.S. or +1
8-K
EX-99.1
QTNTQ
Quotient Ltd
8 Feb 22
Results of Operations and Financial Condition
7:15am
manufacturing line based on market access and targeted market demand.
Scientific & Medical Affairs:
The Company’s Innovator’s Circle initiative aims … . Participants may access the call by dialing 1-877-407-0784 in the U.S. or +1-201-689-8560 outside the U.S. The access code is 13724411. The conference
8-K
EX-99.1
QTNTQ
Quotient Ltd
5 Nov 18
Quotient Limited Reports Positive MosaiQ Audit Results and Instrument CE Mark with Second Quarter Fiscal 2019 Financial Results
6:18am
development plan as they pave the way for European market access and initial commercialization in the first half of 2019.“ commented Franz Walt … results. Participants may access the call by dialing 1-877-407-0784 in the U.S. or 1-201-689-8560 outside the U.S. The conference call will be webcast
8-K
EX-99.1
8090y2cx99rkq
5 Aug 21
Quotient Limited Provides First Quarter Fiscal 2022 Results and Business Update
6:39am
8-K
EX-99.1
ppuu kbmnow
3 Aug 20
Quotient Limited Reports First Quarter Fiscal 2021 Results and Business Update
6:21am
8-K
EX-99.1
o8qw7jjxlf5ip0q0rzb
30 Jan 20
Quotient Limited Provides an Update on Recent MosaiQ Milestone Achievements together with Third Quarter Fiscal 2020 Results
7:00am
8-K
EX-99.1
4z475kr57g5
9 Jun 20
Quotient Limited Provides Update on COVID-19 Antibody Test Progress, Other Key Developments and Fourth Quarter and Full Year Fiscal 2020 Results
7:25am
8-K
EX-99.1
nzhxv9
2 Nov 20
Quotient Limited Reports Second Quarter Fiscal 2021 Results and Business Update
6:16am
DEFA14A
cp6ywb
27 Jul 20
Additional proxy soliciting materials
4:20pm
8-K
EX-99.1
d9sncnl7mmi
1 Feb 21
Quotient Limited Reports Third Quarter Fiscal 2021 Results and Business Update
6:30am
8-K
EX-99.1
64if358zxuy 3j6
1 Jun 21
Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Update
6:30am
8-K/A
EX-99.1
ky5zp
1 Jun 21
Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Update
12:27pm
8-K
EX-99.1
cdnp1i7y g3fzoaf
30 Jan 15
Quotient and Ortho Clinical Diagnostics Establish Exclusive Commercial Partnership
12:00am
8-K
EX-99.1
7e3ndtydw6b
20 May 14
Results of Operations and Financial Condition
12:00am
8-K
ro6mlw4ygr
30 Jan 15
Quotient and Ortho Clinical Diagnostics Establish Exclusive Commercial Partnership
12:00am
8-K
EX-99.1
xvz3srusigtc48
5 Aug 14
CORRECTING and REPLACING Quotient Reports First Quarter Fiscal 2015 Financial Results
12:00am
8-K
EX-99.1
1ftdqvbplsvzj 220s
6 Aug 18
Results of Operations and Financial Condition
4:15pm